Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation?
Braun
F
F
Klinik für Transplantationschirurgie, Georg-August-Universität, Göttingen, Germany.
Rüchel
R
R
Lorf
T
T
Canelo
R
R
Müller
A
A
Sattler
B
B
Ringe
B
B
D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008081:Liposomes; D016031:Liver Transplantation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000517:prevention & control*; D011183:Postoperative Complications
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B